From conventional towards new natural surfactants in drug delivery systems design: Current status and perspectives

Expert Opinion on Drug Delivery

Volumn 7, Issue 3, 2010, Pages 353-369

  Savić, Snezana ^a   Tamburić, Slobodanka ^b   Savić, Miroslav M ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b LONDON COLLEGE OF FASHION   (United Kingdom)

^c Faculty of Pharmacy   (Serbia)

Author keywords

Advanced drug delivery systems; Alkyl polyglucosides; Conventional drug delivery systems; Natural surfactants; Physicochemical behavior

Indexed keywords

DODECYL SULFATE SODIUM; GLUCOSIDE; LIPOSOME; NANOPARTICLE; NIOSOME; POLYSORBATE; SURFACTANT;

COLLOID; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STRUCTURE; HUMAN; NONHUMAN; PATCH TEST; PHYSICAL CHEMISTRY; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

CARBOHYDRATES; COLLOIDS; DRUG DELIVERY SYSTEMS; SURFACE-ACTIVE AGENTS;

EID: 77749295242     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240903535833     Document Type: Review

References (97)

1. Corrigan OI, Healy AM. Surfactants in pharmaceutical products and systems, in Encyclopedia of pharmaceutical technology. M Dekker, New York; 2002
2. Müller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 2004;58:343-56
3. Ashton P, Walters KA, Brain KR, et al. Surfactant effects in percutaneous absorption. II. Effects on protein and lipid structure of the stratum corneum. Int J Pharm 1992;87:265-9
4. European Pharmacopoeia 6.0, European Directorate for Quality of Medicines, Council of Europe, Strasbourg, France; 2008
5. United States Pharmacopeia/National Formulary (USP/NF); 2009
6. British Pharmacopoeia 2009 (BP 2009), British Pharmacopoeia Commission, The Stationery Office, London, UK; 2009
7. Deutsche Arzneibuch 2006 (DAB 2006), German Federal Institute for Drugs and Medicines, Bonn, 2006
8. Bárány E, Lindberg M, Lodén M. Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm 2000;195:189-95
9. OECD (2008). OECD Guideline for the Testing of Chemicals, Draft Proposal for a New Guideline: In Vitro Skin Irritation: Human Skin Model Test. Available from: http://www.oecd.org/searchResult/0,3400,en-2649-201185-1-1-1-1-1,00.html [Last accessed 31 August 2009]
10. Bárány E. Human in vivo skin irritancy testing, in dry skin and moisturizers. CRC Press LLC, Boca Raton; 2000
11. Fluhr JW, Kuss O, Diepgen T, et al. Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types. Br J Dermatol 2001;145:696-703
12. Aikens PA, Friberg SE. Emulsifiers, in dry skin and moisturizers. CRC Press LLC, Boca Raton; 2000
13. Eccleston GM., Functions of mixed emulsifiers and emulsifying waxes in dermatological lotions and creams. Colloids Surf A Physicochem Eng Aspects 1997;123/124:169-182
14. Al-Bawab A, Friberg SE. Some pertinent factors in skin care emulsions. Adv Colloid Interface Sci 2006;123-126:313-322
15. Williams AC, Barry BB. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-18
16. Holmberg K. Natural surfactants. Cur Opin Colloid Interface Sci 2001;6:148-59
17. Stubenrauch K. Sugar surfactants - aggregation, interfacial, and adsorption phenomena. Cur Opin Colloid Interface Sci 2001;6:160-70
18. Johansson I, Svensson M. Surfactants based on fatty acids and other natural hydrophobes. Cur Opin Colloid Interface Sci 2001;6:178-88
19. Hill K. Alkyl polyglycosides: where 'green' meets performance. HPC Focus Surfactants 2008;2:18-22
20. Nickel D, Förster T, von Rybinski W. Physicochemical properties of alkyl polyglycosides, in Alkyl polyglycosides. Weinheim: VCH; 1997
21. von Rybinski W, Hill K. Alkyl polyglycosides - properties and applications of a new class of surfactants. Angew Chem Int Ed Engl 1998;37:1328-45
22. Zhang R, Marone PA, Thiyagarajan P, Tiede DM. Structure and molecular fluctuations of n-alkyl-beta-D-glycopyranoside micelles determined by X-ray and neutron scattering. Langmuir 1999;15:7510-9
23. Sierra ML, Svensson M. Mixed micelles containing alkyl glycosides: effect of the chain length and the polar head group. Langmuir 1999;15:2301-6
24. Boyd BJ, Drummond CJ, Krodkiewska I, Grieser F. How chain length, headgroup polymerization, and anomeric configuration govern the thermotropic and lyotropic liquid crystalline phase behavior and the air-water interfacial adsorption of glucose-based surfactants. Langmuir 2000;16:7359-67
25. Vill V, von Minden HM, Koch MHJ, et al. Thermotropic and lyotropic properties of long chain alkyl glycopyranosides. Part I: monosaccharide headgroups. Chem Phys Lipids 2000;104(1):75-91
26. von Minden HM, Brandenburg K, Seydel U, et al. Thermotropic and lyotropic properties of long chain alkyl glycopyranosides. Part II: disaccharide headgroups. Chem Phys Lipids 2000;106(2):157-79
27. Satam RM, Sawant MR. A study of the solubilization of polar oily materials by alkyl polyglucoside and sodium dodecyl sulfate in mixed surfactant system. J Dispersion Sci Technol 2006;27(2):179-84
28. Fanun M. Liquid crystal structural variability on water/mixed nonionic surfactants/caprylic-capric triglyceride systems. J Dispersion Sci Technol 2009;30(3):289-96
29. Fukuda K, Olsson U, Ueno M. Microemulsions formed by alkyl polyglucoside and alkyl glycerol ether with weakly charged films. Colloid Surf B Biointerfaces 2001;20:129-35
30. Kluge K, Sottmann T, Stubenrauch C, Strey R. Temperature-insensitive microemulsions formulated from octyl monglucoside and alcohols: potential candidates for applications. Tenside Surf Det 2001;38:30-40
31. Mitsubishi Kagaku Food Corporation. Application of sugar esters. 2007. Available from: http://www.mfc.co.jp/english/infor.html [Last accessed 31 August 2009]
32. Garti N, Clement V, Leser M, et al. Sucrose ester microemulsions. J Mol Liq 1999;80:253-96
33. Fanun M, Wachtel E, Antalek B, et al. A study of the microstructure of four-component sucrose ester microemulsions by SAXS and NMR. Colloid Surf A Physicochem Eng Aspects 2001;180:173-86
34. Matthies W, Jackwerth B, Krächter H-U. Dermatological properties of alkyl polyglycosides, in Alkyl polyglycosides. Weinheim: VCH; 1997
35. Mehling A, Hensen H. Comparative studies on the irritation potential of surfactants. Exog Dermatol 2004;3:191-200
36. Mehling A, Kleber M, Hensen H. Comparative studies on the ocular and dermal irritation potential of surfactants. Food Chem Toxicol 2007;45:747-58
37. Aulmann W, Sterzel W. Toxicology of alkyl polyglycosides, in Alkyl polyglycosides. Weinheim: VCH; 1997
38. Messinger H, Aulmann W, Kleber M, Koehl W. Investigations on the effects of alkyl polyglycosides on development and fertility. Food Chem Toxicol 2007;45:1357-82
39. Hadgraft J. Skin deep. Eur J Pharm Biopharm 2004;58:291-9
40. Refai H, Müller-Goymann CC. The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum. Eur J Pharm Biopharm 2002;54:143-50
41. Available from: http://www.seppic.com [Last accessed 31 August 2009]
42. Savic S, Tamburic S, Savic M, et al. Vehicle-controlled effect of urea on normal and SLS-irritated skin. Int J Pharm 2004;271:269-80
43. Savic S, Vuleta G, Daniels R, Müller-Goymann CC. Colloidal microstructure of binary systems and model creams stabilized with an alkylpolyglucoside non-ionic emulsifier. Colloid Polymer Sci 2005;283:439-51
44. Savic S, Vuleta G, Milic J, et al. Structural characterisation of multiphase emulsion systems based on an alkylpolyglucoside non-ionic emulsifier. RISG La Rivista Italiana Delle Sostanze Grasse 2005;82(5):236-44
45. Fairhust C, Fuller S, Gray J, Holmes MC. Lyotropic surfactant liquid crystals, in Handbook of liquid crystals. Volume 3. Weinheim: Wiley-VCH; 1998
46. Müller-Goymann CC, Drug delivery - liquid crystals in, in Encyclopedia of pharmaceutical technology. Volume 1. Marcel Dekker, New York; 2002
47. Eccleston GM, Behan-Martin MK, Jones GR, Towns-Andrews E. Synchrotron X-ray investigations into the lamellar gel phase formed in pharmaceutical creams prepared with cetrimide and fatty alcohols. Int J Pharm 2000;203:127-39
48. Junginger HE. Multiphase emulsions, in Surfactants in cosmetics. Marcel Dekker, New York; 1997
49. Mondain-Monval O. Freeze fracture TEM investigations in liquid crystals. Curr Opin Colloid Interf Sci 2005;10:250-5
50. Makai M, Csanyi E, Nemeth Z, et al. Structure and drug release of lamellar liquid crystals containing glycerol. Int J Pharm 2003;256:95-107
51. Erös I, Kónya M, Csóka I. Study of the structure of coherent emulsions. Int J Pharm 2003;256:75-84
52. Makai M, Csanyi E, Dékány I, et al. Structural properties of nonionic surfactant/glycerol/paraffin lyotropic liquid crystals. Colloid Polym Sci 2003;281:839-44
53. Korhonen M, Lehtonen J, Hellen L, et al. Rheological properties of three component creams containing sorbitan monoesters as surfactants. Int J Pharm 2002;247:103-14
54. Robles-Vasquez O, Corona-Galvan S, Soltero JFA, et al. Rheology of lyotropic liquid crystals of Aerosol OT. II. High concentration regime. J Colloid Interface Sci 1993;160:65-71
55. Nemeth Z, Halasz L, Palinkas J, et al. Rheological behaviour of a lamellar liquid crystalline surfactant-water system. Colloid Surf A 1998;145:107-19
56. Masmoudi H, Piccerelle P, Le Dréau Y, Kister J. A rheological method to evalauate the physical stability of highly viscous pharmaceutical oil-in-water emulsions. Pharm Res 2006;23(8):1937-1947
57. Savic S, Tamburic S, Kovacevic A, et al. Natural surfactant-based emulsion systems: the influence of common pharmaceutical excipients on colloidal structure and physical stability. J Dispersion Sci Technol 2008;29:1276-87
58. Baudonnet L, Grossiord J-L, Rodriguez F. Physicochemical characterization and in vitro release of salicylic acid from o/w emulsions prepared with Montanov 68®: effect of formulation parameters. Drug Dev Ind Pharm 2004;30 (9):975-984
59. Savić SD, Savić MM, Vesić SA, et al. Vehicles based on a sugar surfactant: colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation. Int J Pharm 2006;320:86-95
60. Savic S, Savic M, Tamburic S, et al. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation. Eur J Pharm Sci 2007;30:441-50
61. Vucinic-Milankovic N, Savic S, Vuleta G, Vucinic S. The physicochemical characterization and in vitro/in vivo evaluation of natural surfactants-based emulsions as vehicles for diclofenac diethylamine. Drug Dev Ind Pharm 2007;33:1-14
62. Savic S, Tamburic S, Jancic B, et al. The impact of urea on the colloidal structure of alkylpolyglucoside-based emulsions: physicochemical and in vitro/in vivo characterization, in Colloids in cosmetic and personal care. Weinheim: Wiley-VCH; 2008
63. Savic S, Weber C, Tamburic S, et al. Topical vehicles based on natural surfactants/fatty alcohols mixed emulsifier: the influence of two polyolos on the colloidal structure and in vitro/in vivo skin performance. J Pharm Sci 2009;98(6):2073-90
64. Savic S, Weber C, Savic M, Müller-Goymann C. Natural surfactant-based topical vehicles for two model drugs: influence of different lipophilic excipients on in vitro/in vivo skin performance. Int J Pharm 2009;381:220-30
65. Ponec M. Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Del Rev 2002;54(Suppl 1):S19-30
66. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001;215:51-6
67. Hoffmann C, Müller-Goymann CC. Use of artificial skin constructs in permeation studies of clindamycin phosphate. Pharmazie 2005;60:350-3
68. Schäfer-Korting M, Bock U, Diembeck W, et al. The use of reconstructed human epidermis for skin absorption testing: results of the validation study. ATLA 2008;36:161-87
69. Bolzinger MA, Briançon S, Pelletier J, et al. Percutaneous release of caffeine from microemulsions, emulsions and gel dosage forms. Eur J Pharm Biopharm 2008;68:446-51
70. Fang JY, Leu YL, Fang CL, Chiu HC. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 2003;255:153-66
71. Roberts MS, Walker M. Water: the most natural penetration enhancer, in Pharmaceutical skin enhancement. New York: Marcel Dekker; 1993
72. Lodèn M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003;4:771-88
73. Gloor M, Gehring W. O/W emulsions compromise the stratum corneum barrier and improve drug penetration. Pharmazie 2003;58:709-15
74. Adams WP, Singh GJP. Guidance: topical dermatologic corticosteroids: in vivo bioequivalence, Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration, 1995
75. Lehmann L, Keipert S, Gloor M. Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm 2001;52:129-36
76. Clarys P, Alewaeters K, Lambrecht R, Barel AO. Skin color measurements: comparison between three instruments: the Chromameter®, the DermaSpectrometer® and the Mexameter®. Skin Res Technol 2000;6:230-8
77. Fullerton A, Fischer T, Lahti A, et al. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1996;35:1-10
78. Haigh JM, Meyer E, Smith EW, Kanfer I. The human skin blanching assay for in vivo topical corticosteroid assessment. I. Reproducibility of the assay. Int J Pharm 1997;152:179-83
79. Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release 2005;103:291-9
80. Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: an overview. Skin Pharmacol Appl Skin Physiol 2001;14:1-10
81. Panchagnula R, Salve PS, Thomas NS, et al. Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 2001;219:95-105
82. Trottet L, Merly C, Mirza M, et al. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int J Pharm 2004;274:213-9
83. Herkenne C, Naik A, Kalia YN, et al. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J Pharm Sci 2008;97:185-97
84. Weyermann J, Lochmann D, Zimmer A.A practical note on the use of cytotoxicity assays. Int J Pharm 2005;288:369-76
85. Vinardell MP, Mitjans M. Alternative methods for eye and skin irritation tests: an overview. J Pharm Sci 2008;97:46-59
86. Ayala-Bravo HA, Quintanar-Guerrero D, Naik A, et al. Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability. Pharm Res 2003;20(8):1267-73
87. Quintanar-Ganem A, Quintanar-Guerrero D, Falson-Rieg F, Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int J Pharm 1998;173:203-10
88. Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006;311:11-9
89. Rentel C-O, Bouwstra JA, Naisbett B, Junginger HE. Niosomes as a novel peroral vaccine delivery system. Int J Pharm 1999;186:161-7
90. Csóka G, Marton S, Zelko R, et al. Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J Pharm Biopharm 2007;65:233-7
91. Patel AR, Joshi VY. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. AAPS PharmSciTech 2008;9(2):583-90
92. Patel AR, Kulkami S, Nandeker TD, Vavia PR. Evaluation of alkyl polyglucoside as an alternative surfactant in the preparation of peptide-loaded nanoparticles. J Microencapsul 2008;25(8):531-40
93. Graf A, Ablinger E, Peters S, et al. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm 2008;350:351-60
94. Youan BB, Hussian A, Nguyen NT. Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method. AAPS PharmSciTech 2003;5:222-30
95. Ullrich S, Metz H, Mäder K. Sucrose ester nanodispersions: Microviscosity and viscoelastic properties. Eur J Pharm Biopharm 2008;70:550-5
96. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278-87
97. Pakpayat N, Nielloud F, Fortuné R, et al. Formulation of ascorbic acid microemulsions with alkyl polyglycosides. Eur J Pharm Biopharm 2009;72:444-52